Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke

Stroke

Volumn 33, Issue 9, 2002, Pages 2197-2203

  Arenillas, Juan F ^a   Rovira, Álex ^a   Molina, Carlos A ^a   Grivé, Elisenda ^a   Montaner, Joan ^a   Álvarez Sabín, José ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Brain edema; Magnetic resonance imaging; Stroke outcome; Stroke, acute; Ultrasonography, Doppler, transcranial

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN PERFUSION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; EARLY DIAGNOSIS; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; STROKE;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CAROTID ARTERY DISEASES; DIFFUSION; DISEASE PROGRESSION; FEMALE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; LOGISTIC MODELS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036712388     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000027861.75884.DF     Document Type: Article

References (44)

1. Neurological deterioration in acute ischemic stroke: Potential predictors and associated factors in the European Cooperative Acute Stroke Study (ECASS) I
2. Progressing neurological deficit secondary to acute ischemic stroke: A study of predictability, pathogenesis and prognosis
3. Predictors of deteriorating cerebral infarct: Role of inflammatory mechanisms: Would its early treatment be useful?
4. Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project
5. Progression of ischemic stroke and excitotoxic aminoacids
6. Duration of glutamate release after acute ischemic stroke
7. Proinflammatory cytokines and early neurological worsening in ischemic stroke
8. Matrix metalloproteinase expression after human cardioembolic stroke: Temporal profile and relation to neurological impairment
9. Decompressive craniectomy in a rat model of "malignant" cerebral hemispheric stroke: Experimental support for an aggressive therapeutic approach
10. Early hemicraniectomy in patients with complete middle cerebral artery infarction
11. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction
12. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome
13. Prediction of stroke outcome with echoplanar perfusion and diffusion-weighted MRI
14. Clinical correlations of diffusion and perfusion lesion volumes in acute ischemic stroke
15. Correlation of perfusion- and diffusion weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke
16. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome
17. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia
18. Diffusion-weighted magnetic resonance imaging in acute stroke
19. Diffusion-weighted magnetic resonance imaging: Detection of ischemic injury 39 minutes after onset in a stroke patient
20. Comparison of CT with diffusion-weighted MRI in patients with hyperacute stroke
21. Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging
22. Improved reliability of the NIH Stroke Scale using video training
23. Tissue plasminogen activator for acute ischemic stroke
24. Thrombolytic agents in the treatment of stroke
25. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS)
26. Doppler diagnosis of intracranial occlusive disorders
27. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries
28. Spontaneous middle cerebral artery reperfusion in ischemic stroke: A follow-up study with transcranial Doppler
29. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II)
30. European Stroke Initiative recommendations for stroke management
31. 99mtechnetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema
32. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk
33. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke
34. Predictors of fatal brain edema in massive hemispheric ischemic stroke
35. Attenuated corticomedullary contrast: An early cerebral computed tomography sign indicating malignant middle cerebral artery infarction: A case control study
36. Significance of early CT signs in acute stroke: A CT scan-diffusion MRI study
37. Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariate analysis
38. Malignant middle cerebral artery territory infarction: Clinical course and prognostic signs
39. Relationship between cerebral blood flow and the development of swelling and life-threatening herniation in acute ischemic stroke
40. Tissue viability thresholds in acute stroke: The 4-factor model
41. Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: A case-control study
42. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging
43. Is there an apparent diffusion coefficient threshold in predicting tissue viability in hyperacute stroke?
44. Magnetic resonance perfusion-weighted imaging of acute cerebral infarction: Effect of the calculation methods and underlying vasculopathy